Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Shigella sonnei isolated from cases of diarrhoeal disease in England and Wales, 2015

Journal of Antimicrobial Chemotherapy

Volumn 72, Issue 9, 2017, Pages 2496-2502

  Sadouki, Zahra ^a,b   Day, Martin R ^a   Doumith, Michel ^a   Chattaway, Marie A ^a   Dallman, Timothy J ^a   Hopkins, Katie L ^a   Elson, Richard ^a   Woodford, Neil ^a   Godbole, Gauri ^a   Jenkins, Claire ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; AZITHROMYCIN; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; ERTAPENEM; GENTAMICIN; NALIDIXIC ACID; STREPTOMYCIN; SULFONAMIDE; TEMOCILLIN; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TOBRAMYCIN; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; DIARRHEA; ENGLAND; FEMALE; GENE MAPPING; HUMAN; MALE; SHIGELLA SONNEI; WALES; WHOLE GENOME SEQUENCING; BACTERIAL GENOME; CHILD; CLASSIFICATION; COMPARATIVE STUDY; DRUG EFFECTS; GENETICS; GENOTYPE; HIGH THROUGHPUT SEQUENCING; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; PHENOTYPE; PULSED FIELD GEL ELECTROPHORESIS; SHIGELLOSIS; TRAVEL RELATED DISEASE;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; DIARRHEA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DYSENTERY, BACILLARY; ELECTROPHORESIS, GEL, PULSED-FIELD; ENGLAND; FEMALE; GENOME, BACTERIAL; GENOTYPE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; SHIGELLA SONNEI; TRAVEL-RELATED ILLNESS; WALES; WHOLE GENOME SEQUENCING;

EID: 85042202573     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkx170     Document Type: Article

References (28)

1. Kim Y, Hahn S, Garner P. Reduced osmolarity oral rehydration solution for treating dehydration caused by acute diarrhoea in children. Cochrane Database Syst Rev 2001; issue 2: CD002847
2. Hawker J, Begg N, Blair I et al. Communicable Disease Control and Health Protection Handbook. 3rd edn. Chichester, UK:Wiley-Blackwell, 2012
3. Christopher PR, David KV, John SM et al. Antibiotic therapy for Shigella dysentery. Cochrane Database Syst Rev 2010; issue 8: CD006784
4. Chung The H, Rabaa MA, Pham Thanh D et al. South Asia as a reservoir for the global spread of ciprofloxacin-resistant Shigella sonnei: a cross-sectional study. PLoS Med 2016; 13: e1002055
5. Arcilla MS, van Hattem JM, Haverkate MR et al. Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study. Lancet Infect Dis 2017; 17: 78-85
6. Cheasty T, Skinner JA, Rowe B et al. Increasing incidence of antibiotic resistance in shigellas fromhumans in England andWales: recommendations for therapy. Microb Drug Resist 1998; 4: 57-60
7. Cheasty T, Day M, Threlfall EJ. Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy. ClinMicrobiol Infect 2004; 10: 1033-5
8. Agodi A, Jones C, Threlfall EJ et al. Molecular characterization of trimethoprim resistance in Shigella sonnei in Sicily. Epidemiol Infect 1990; 105: 29-40
9. Dallman TJ, Chattaway MA, Mook P et al. Use of whole-genome sequencing for the public health surveillance of Shigella sonnei in England and Wales, 2015. JMedMicrobiol 2016; 65: 882-4
10. Ellington MJ, Ekelund O, Aarestrup FM et al. The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee. Clin Microbiol Infect 2017; 23: 2-22
11. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. NatMethods 2012; 9: 357-9
12. Magiorakos A-P, Srinivasan A, Carey RB et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268-81
13. Enne VI, Delsol AA, Roe JM et al. Evidence of antibiotic resistance gene silencing in Escherichia coli. Antimicrob Agents Chemother 2006; 50: 3003-10
14. Cohen D, Bassal R, Goren S et al. Recent trends in the epidemiology of shigellosis in Israel. Epidemiol Infect 2014; 142: 2583-94
15. Zhang J, Jin H, Hu J et al. Antimicrobial resistance of Shigella spp. from humans in Shanghai, China, 2004-2011. Diagn Microbiol Infect Dis 2014; 78: 282-6
16. Lluque A, Mosquito S, Gomes C et al. Virulence factors and mechanisms of antimicrobial resistance in Shigella strains from periurban areas of Lima (Peru). Int J MedMicrobiol 2015; 305: 480-90
17. Ud-Din AI, Wahid SU, Latif HA et al. Changing trends in the prevalence of Shigella species: emergence of multi-drug resistant Shigella sonnei biotype g in Bangladesh. PLoS One 2013; 8: e82601
18. Holt KE, Thieu Nga TV, Thanh DP et al. Tracking the establishment of local endemic populations of an emergent enteric pathogen. Proc Natl Acad Sci USA 2013; 110: 17522-7
19. De Lappe N, O'Connor J, Garvey P et al. Ciprofloxacin-resistant Shigella sonnei associated with travel to India. Emerg Infect Dis 2015; 21: 894-6
20. Taneja N, Mewara A. Shigellosis: epidemiology in India. Indian J Med Res 2016; 143: 565-76
21. Vasilev V, Japheth R, Yishai R et al. Extended-spectrum β-lactamase-producing Shigella strains in Israel, 2000-2004. Eur J Clin Microbiol Infect Dis 2007; 26: 189-94
22. Xiong Z, Li T, Xu Y, Li J. Detection of CTX-M-14 extended-spectrumb-lactamase in Shigella sonnei isolates from China. J Infect 2007; 55: e125-8
23. Acikgoz ZC, Gulay Z, Bicmen M et al. CTX-M-3 extended-spectrum β-lactamase in a Shigella sonnei clinical isolate: first report from Turkey. Scand J Infect Dis 2003; 35: 503-5
24. Mook P, McCormick J, Bains M et al. ESBL-producing and macrolideresistant Shigella sonnei infections among men who have sex with men, England, 2015. Emerg Infect Dis 2016; 22: 1948-52
25. Baker KS, Dallman TJ, Ashton PM et al. Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a crosssectional study. Lancet Infect Dis 2015; 15: 913-21
26. Nair S, Ashton P, DoumithMet al. WGS for surveillance of antimicrobial resistance: a pilot study to detect the prevalence and mechanismof resistance to azithromycin in a UK population of non-typhoidal Salmonella. J Antimicrob Chemother 2016; 71: 3400-8
27. Bowen A, Eikmeier D, Talley P et al. Notes from the field: outbreaks of Shigella sonnei infectionwith decreased susceptibility to azithromycin among men who have sex with men-Chicago and Metropolitan Minneapolis-St. Paul, 2014. MMWRMorbMortalWkly Rep 2015; 64: 597-8
28. Heiman KE, Grass JE, Sjölund-Karlsson M, Bowen A. Shigellosis with decreased susceptibility to azithromycin. Pediatr Infect Dis J 2014; 33: 1204-5